Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Endocrine. 2023 Oct;82(1):134-142. doi: 10.1007/s12020-023-03416-5. Epub 2023 Jul 29.
Obesity is associated with an increased risk of papillary thyroid carcinoma (PTC). Evidence of the impact of obesity on PTC aggressiveness is scarce. We aimed to evaluate the association between the body mass index (BMI) and the presence of aggressive features of low- to intermediate-risk PTC in a prospective cohort.
We prospectively enrolled 1,032 patients with low- to intermediate-risk PTC who underwent lobectomy at 22 hospitals in Korea and divided into three groups according to BMI, as follows: normal/underweight ( < 23 kg/m), overweight (23-24.9 kg/m), and obese ( ≥ 25 kg/m). Clinicopathological features of PTC at diagnosis were evaluated.
Obese patients had a higher rate of macro-PTC ( > 1 cm) and greater incidence of extra-thyroidal extension (ETE), vascular invasion, and intermediate-risk tumors than those not classified as obese. Increased BMI was positively associated with the incidence of macro-PTC, ETE, vascular invasion, and intermediate-risk category. After adjusting for age, sex, pathological features, metabolic syndrome, thyroid function test, and smoking habits, obesity was a risk factor for ETE (odds ratio [OR] = 1.7, 95% confidence interval [CI]: 1.2-2.5, p = 0.005) and intermediate-risk PTC (OR = 1.7, 95% CI: 1.1-2.5, p = 0.011) in women. The association between obesity and ETE was significant regardless of whether or not women had metabolic syndrome. There was no significant association between obesity and aggressive PTC features in men.
BMI at the time of thyroid cancer diagnosis may affect the aggressiveness of low- to intermediate-risk PTC, especially in women.
肥胖与甲状腺乳头状癌(PTC)风险增加相关。肥胖对 PTC 侵袭性的影响证据有限。本研究旨在评估体质量指数(BMI)与韩国 22 家医院接受甲状腺叶切除术的低-中危 PTC 患者侵袭性特征之间的关系。
我们前瞻性纳入了 1032 例低-中危 PTC 患者,根据 BMI 将患者分为三组:正常/体重不足(<23kg/m²)、超重(23-24.9kg/m²)和肥胖(≥25kg/m²)。评估了患者 PTC 诊断时的临床病理特征。
与未肥胖患者相比,肥胖患者中更大比例的患者患有巨 PTC(>1cm),并且发生甲状腺外侵犯(ETE)、血管侵犯和中危肿瘤的发生率更高。BMI 增加与大 PTC、ETE、血管侵犯和中危类别发生率的增加呈正相关。在校正年龄、性别、病理特征、代谢综合征、甲状腺功能检查和吸烟习惯后,肥胖是 ETE(优势比 [OR] = 1.7,95%置信区间 [CI]:1.2-2.5,p=0.005)和女性中危 PTC(OR=1.7,95% CI:1.1-2.5,p=0.011)的危险因素。无论女性是否患有代谢综合征,肥胖与 ETE 之间的关联均具有统计学意义。肥胖与男性侵袭性 PTC 特征之间无显著相关性。
甲状腺癌诊断时的 BMI 可能会影响低-中危 PTC 的侵袭性,尤其是在女性中。